Aileron | Jotup

Aileron Therapeutics Announces Closing of Underwritten Registered Direct Offering of up to Approximately $40 Million

Retrieved on:

Friday, May 3, 2024

Titan, Sale, Idiopathic pulmonary fibrosis, Prospectus, Aileron, ALRN, Security (finance), Form, Exercise, Patient, Fibrosis, S-3, Therapy

Each share of common stock and accompanying warrant were sold together at a combined public offering price of $4.68.

Key Points:

Each share of common stock and accompanying warrant were sold together at a combined public offering price of $4.68.
The aggregate gross proceeds of the offering were approximately $20 million, before deducting underwriting discounts and commissions and other offering expenses payable by Aileron, and excluding any proceeds that may be received from exercise of the warrants.
Titan Partners Group, a division of American Capital Partners, acted as sole book-running manager for the offering.
The offering was made only by means of a prospectus supplement and the accompanying prospectus that form a part of the registration statement.

Aileron Therapeutics to Host Key Opinion Leader Event on February 15, 2024

Retrieved on:

Thursday, February 1, 2024

University of Giessen, Intensive care medicine, Physician, Therapy, Fibrosis, Aileron, ID, ALRN, Webcast, Interstitial, Internal

WALTHAM, Mass., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Aileron Therapeutics, Inc. (“Aileron”) (NASDAQ: ALRN), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis indications, today announced that it will host a virtual key opinion leader event titled, “Clinical Perspectives on Treating Idiopathic Pulmonary Fibrosis” on Thursday, February 15, 2024, from 4:30 to 5:30 p.m.

Key Points:

WALTHAM, Mass., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Aileron Therapeutics, Inc. (“Aileron”) (NASDAQ: ALRN), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis indications, today announced that it will host a virtual key opinion leader event titled, “Clinical Perspectives on Treating Idiopathic Pulmonary Fibrosis” on Thursday, February 15, 2024, from 4:30 to 5:30 p.m.
Aileron management will be joined by pulmonary care medicine experts including:
Andreas Günther, M.D., Senior Physician of Pulmonology and Intensive Care Medicine and Chief Physician of Pulmonology and Internal Intensive Care Medicine at Agaplesion Evang.
To access the event, please dial +1 646-876-9923 (domestic) or +44 208-080-6591 (international) and reference webinar ID: 953 9620 1729 and passcode: 554257 when prompted by the operator.
A replay of the webcast will be available following the completion of the event.

SUNSEEKER RESORT CHARLOTTE HARBOR IS NOW OPEN

Retrieved on:

Monday, December 18, 2023

PGD, Collection, Sunseeker, Aileron, News, Love, Allegiant, Allegiant Travel Company, Punta Gorda Airport, Travel, Senior, Hotel

PORT CHARLOTTE, Fla., Dec. 18, 2023 /PRNewswire/ -- The highly anticipated Sunseeker Resort Charlotte Harbor is now open as they welcomed their first guests on December 15, 2023. The independently flagged property features 785 well-appointed guest rooms including 189 top-tier luxury Sunsuites™ and is the first completely new-build resort with more than 750 rooms to open in Southwest Florida in over thirteen years.

Key Points:

PORT CHARLOTTE, Fla., Dec. 18, 2023 /PRNewswire/ -- The highly anticipated Sunseeker Resort Charlotte Harbor is now open as they welcomed their first guests on December 15, 2023.
To commemorate the opening, Sunseeker Resort Charlotte Harbor hosted a ribbon-cutting ceremony along with local officials including Charlotte County Commissioner Bill Truex and the Sunseeker Resort executive team including President Micah Richins, Senior Vice President Jason Shkorupa, and their entire executive committee as they welcomed the first guests.
"Simply put, there is not a single collection of hotel amenities that rival Sunseeker Resort Charlotte Harbor along the Gulf Coast.
Sunseeker Resort Charlotte Harbor is located at 5500 Sunseeker Way, Charlotte Harbor, FL 33980.

SUNSEEKER RESORT CHARLOTTE HARBOR TO OFFICIALLY WELCOME ITS FIRST GUESTS DECEMBER 15, 2023

Retrieved on:

Thursday, November 2, 2023

The Newest Pledge, PORT, News, PGD, Aileron, Punta Gorda Airport, Hotel, Gulf Coast of the United States

PORT CHARLOTTE, Fla., Nov. 2, 2023 /PRNewswire/ -- The highly anticipated Sunseeker Resort Charlotte Harbor announces an official opening date of December 15, 2023. The independently flagged property features 785 well-appointed guest rooms including 189 top-tier luxury Sunsuites™, and will be the first completely new-build resort with more than 750 rooms to open in Southwest Florida in over thirteen years.

Key Points:

The highly anticipated Sunseeker Resort Charlotte Harbor announces an official opening date of December 15, 2023.
In addition to its prime waterfront location, Sunseeker Resort Charlotte Harbor will feature a world class 18-hole golf course, Aileron Golf Club, exclusive to hotel guests.
Guests staying at Sunseeker Resort Charlotte Harbor will be able to pick from a signature list of guestrooms and suites.
Sunseeker Resort Charlotte Harbor is located at 5500 Sunseeker Way, Charlotte Harbor, FL 33980.

Aileron Therapeutics Announces Acquisition of Lung Therapeutics

Retrieved on:

Tuesday, October 31, 2023

WALTHAM, Mass. and AUSTIN, Texas, Oct. 31, 2023 /PRNewswire/ -- Aileron Therapeutics, Inc. ("Aileron") (NASDAQ: ALRN) today announced it has acquired Lung Therapeutics, Inc. ("Lung Tx"), a privately held biopharmaceutical company focused on developing novel therapies for the treatment of orphan pulmonary and fibrosis indications that have no approved or limited effective treatments. Immediately following the acquisition of Lung Tx, Aileron entered into a definitive agreement for the sale of shares of Aileron's Series X non-voting convertible preferred stock (the "Series X preferred stock") and warrants to purchase shares of Aileron's common stock in a private placement to a group of accredited investors led by Bios Partners ("Bios"), and including Nantahala Capital, as well as additional undisclosed investors. The private placement is expected to result in gross proceeds to Aileron of approximately $18 million before deducting placement agent fees and other offering expenses. Aileron intends to use the proceeds from the private placement primarily to complete the ongoing Phase 1b clinical study of LTI-03, a Caveolin-1-related peptide in development for the treatment of IPF, and for general corporate purposes.

Key Points:

and AUSTIN, Texas, Oct. 31, 2023 /PRNewswire/ -- Aileron Therapeutics, Inc. ("Aileron") (NASDAQ: ALRN) today announced it has acquired Lung Therapeutics, Inc. ("Lung Tx"), a privately held biopharmaceutical company focused on developing novel therapies for the treatment of orphan pulmonary and fibrosis indications that have no approved or limited effective treatments.
"We are pleased to announce that after a thorough evaluation of strategic alternatives, we have completed the acquisition of Lung Therapeutics, which we believe represents a value-creation opportunity for Aileron's stockholders.
"Lung Therapeutics has built a promising clinical-stage pipeline for life-threatening lung conditions, and we believe in the ability of our combined companies to deliver value to both patients and stockholders."
I want to thank the board and entire team of Lung Therapeutics for all their hard work with this transaction."

Aileron Golf Club, Southwest Florida's Ultimate Golf Destination, Awaits Sunseeker Resort Guests This Fall

Retrieved on:

Wednesday, April 26, 2023

Learning, Sunseeker, Charlotte Harbor, Hong Kong Aviation Club, The Ballpark at Harbor Yard, The, Golf, Food, Crave, Motion, News, Aileron, Hotel

PUNTA GORDA, Fla., April 26, 2023 /PRNewswire/ -- The highly-anticipated Sunseeker Resort Charlotte Harbor is set to bring more than just traditional resort style amenities to Southwest Florida's Gulf Coast with Aileron Golf Club. The course will be home to the finest in golf course design with rolling fairways, strategic waterways, mounded greens and framed bulk heads, opening exclusively for resort guests this October.

Key Points:

PUNTA GORDA, Fla., April 26, 2023 /PRNewswire/ -- The highly-anticipated Sunseeker Resort Charlotte Harbor is set to bring more than just traditional resort style amenities to Southwest Florida's Gulf Coast with Aileron Golf Club.
Designed by renowned golf course architect and former collegiate golfer Kipp Schulties, Aileron Golf Club will offer Sunseeker guests the ultimate resort-level golf experience.
Aileron Golf Club, which is expected to open alongside the resort in October 2023, is located just minutes from the resort with complimentary shuttle services available for all guests.
For more information on Aileron Golf Club or to book a reservation at Sunseeker Resort Charlotte Harbor, visit www.sunseekerresorts.com or call (833) 909-5700.

Aileron Therapeutics Announces Termination of Phase 1b Breast Cancer Chemoprotection Trial and Exploration of Strategic Alternatives

Retrieved on:

Tuesday, February 21, 2023

BOSTON, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN) today announced that a review of initial data from its Phase 1b chemoprotection trial of ALRN-6924 in patients with p53-mutated breast cancer showed that patients in the trial experienced severe neutropenia (Grade 4) and alopecia.

Key Points:

BOSTON, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN) today announced that a review of initial data from its Phase 1b chemoprotection trial of ALRN-6924 in patients with p53-mutated breast cancer showed that patients in the trial experienced severe neutropenia (Grade 4) and alopecia.
Based on these findings, Aileron has decided to terminate the Phase 1b breast cancer trial and further development of ALRN-6924.
Aileron also announced that it is exploring a range of strategic alternatives to maximize shareholder value.
The company plans to retain the remaining employees to assist in executing the strategic alternatives review process.

SUNSEEKER RESORT'S SUNSUITES INTRODUCE COASTAL LUXURY TO CHARLOTTE HARBOR, FLORIDA

Retrieved on:

Wednesday, February 8, 2023

Quartz, Glass, Element, Sobel, Charlotte Harbor, System, Transport, Lotus, Aileron, Relaxation, VIP, Bed, The Room, Environment, Hotel, Nespresso, Iris

PUNTA GORDA, Fla., Feb. 8, 2023 /PRNewswire/ -- Tucked inside Sunseeker Resort Charlotte Harbor, Sunsuites™ is an enclave of one, two and three bedroom suites paying homage to the coastal luxury lifestyle of Southwest Florida and its surrounding communities. Designed for the sophisticated and discerning traveler, Sunsuites will feature best in class amenities that rival and exceed the world's best resorts.

Key Points:

PUNTA GORDA, Fla., Feb. 8, 2023 /PRNewswire/ -- Tucked inside Sunseeker Resort Charlotte Harbor , Sunsuites™ is an enclave of one, two and three bedroom suites paying homage to the coastal luxury lifestyle of Southwest Florida and its surrounding communities.
SUNSEEKER RESORT'S SUNSUITES INTRODUCE COASTAL LUXURY TO CHARLOTTE HARBOR, FLORIDA
Sunsuites , a hotel-within-hotel, will offer 189 luxury suites with one-to-three-bedroom accommodations ranging from 875 to 1,700 square feet.
"Sunsuites offers Southwest Florida a new unique level of luxury with sophisticated accommodations in an exclusive environment that is tucked away yet easily accessible to all of Sunseeker Resort," says Sunseeker Resort's Paul A. Berry, Vice President of Hotel, Sales & Marketing.
The amenity-rich Sunseeker Resort will feature elevated experiences for Sunsuites guests including a relaxing private lounge with fully stocked amenities.

Aileron Therapeutics Regains Compliance with Nasdaq Listing Requirements

Retrieved on:

Wednesday, November 30, 2022

ALRN, Aileron, Therapy, Patient, Security (finance), Annual report, Cancer, Coronavirus, Form 10-K, Pharmaceutical industry

Nasdaq staff made this determination after Ailerons closing bid price was above$1.00per share for 10 consecutive business days from November 11, 2022 to November 25, 2022.

Key Points:

Nasdaq staff made this determination after Ailerons closing bid price was above$1.00per share for 10 consecutive business days from November 11, 2022 to November 25, 2022.
Aileron is a clinical stage chemoprotection oncology company that aspires to make chemotherapy safer and thereby more effective to save more patients lives.
ALRN-6924, our first-in-class MDM2/MDMX dual inhibitor, is designed to activate p53, which in turn upregulates p21, a known inhibitor of the cell replication cycle.
Our targeted strategy is designed to selectively protect multiple healthy cell types throughout the body from chemotherapy without protecting cancer cells.

Aileron Therapeutics Announces a 1-for-20 Reverse Stock Split

Retrieved on:

Thursday, November 10, 2022

GLOBE, Nasdaq, Aileron, Bangladesh Securities and Exchange Commission, Annual report, Computershare, Private Securities Litigation Reform Act, ALRN, Therapy, CUSIP, Exercise, Coronavirus, Compliance, Cancer, Form 10-K, Patient, Security (finance), Trust, Pharmaceutical industry

The new CUSIP number for the companys common stock following the reverse stock split will be 00887A 204.

Key Points:

The new CUSIP number for the companys common stock following the reverse stock split will be 00887A 204.
No fractional shares of common stock will be issued as a result of the reverse stock split.
The reverse stock split will affect all stockholders uniformly and will not alter any stockholders percentage interest in Ailerons equity, except to the extent that the reverse stock split would result in a stockholder owning a fractional share.
Stockholders owning shares via a broker, bank, trust, or other nominee will have their positions automatically adjusted to reflect the reverse stock split, subject to such broker's particular processes, and will not be required to take any action in connection with the reverse stock split.